You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application

In this emerging in the form of cooperation, biological medicine industry further extended to the biological agents in the form of outsourcing cooperation contract development and manufacturing organization (CDMO) mode, the CDMO from preclinical studies and clinical trials to commercial production stage and the enterprise research and development, procurement, production, such as depth of the whole supply chain system docking, provide enterprises with innovative technology research and development and large-scale production services, in the higher value-added technology output instead of the pure output capacity.
Market Analysis and Insights: Global Biologics Contract Development and Manufacturing Organization(CDMO) Market
The global Biologics Contract Development and Manufacturing Organization(CDMO) market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Biologics Contract Development and Manufacturing Organization(CDMO) Scope and Segment
The global Biologics Contract Development and Manufacturing Organization(CDMO) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biologics Contract Development and Manufacturing Organization(CDMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Biologics Contract Development Services
Biologics Contract Manufacturing Services
By the application, this report covers the following segments
Big Pharma
Small Pharma
Generic Pharma
Other
Competitive Landscape:
The Biologics Contract Development and Manufacturing Organization(CDMO) key manufacturers in this market include:
Lonza
Hansen
Boehringer Ingelheim BioXcellence
Thermo Fisher Scientific
Samsung BioLogics
AGC Biologics
Catalent
Wuxi Biologics
1 Market Overview of Biologics Contract Development and Manufacturing Organization(CDMO)
1.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Overview
1.1.1 Biologics Contract Development and Manufacturing Organization(CDMO) Product Scope
1.1.2 Market Status and Outlook
1.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2015-2026)
1.4 Global Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Size by Region (2015-2020)
1.5 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2015-2026)
1.6.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2015-2026)
1.6.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2015-2026)
1.6.3 China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2015-2026)
1.6.5 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2015-2026)

2 Biologics Contract Development and Manufacturing Organization(CDMO) Market Overview by Type
2.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Size by Type (2015-2020)
2.3 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Type (2021-2026)
2.4 Biologics Contract Development Services
2.5 Biologics Contract Manufacturing Services

3 Biologics Contract Development and Manufacturing Organization(CDMO) Market Overview by Application
3.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Size by Application (2015-2020)
3.3 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Application (2021-2026)
3.4 Big Pharma
3.5 Small Pharma
3.6 Generic Pharma
3.7 Other

4 Global Biologics Contract Development and Manufacturing Organization(CDMO) Competition Analysis by Players
4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) as of 2019)
4.3 Date of Key Manufacturers Enter into Biologics Contract Development and Manufacturing Organization(CDMO) Market
4.4 Global Top Players Biologics Contract Development and Manufacturing Organization(CDMO) Headquarters and Area Served
4.5 Key Players Biologics Contract Development and Manufacturing Organization(CDMO) Product Solution and Service
4.6 Competitive Status
4.6.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Lonza
5.1.1 Lonza Profile
5.1.2 Lonza Main Business and Company’s Total Revenue
5.1.3 Lonza Products, Services and Solutions
5.1.4 Lonza Revenue (US$ Million) (2015-2020)
5.1.5 Lonza Recent Development and Reaction to Covid-19
5.2 Hansen
5.2.1 Hansen Profile
5.2.2 Hansen Main Business and Company’s Total Revenue
5.2.3 Hansen Products, Services and Solutions
5.2.4 Hansen Revenue (US$ Million) (2015-2020)
5.2.5 Hansen Recent Development and Reaction to Covid-19
5.3 Boehringer Ingelheim BioXcellence
5.5.1 Boehringer Ingelheim BioXcellence Profile
5.3.2 Boehringer Ingelheim BioXcellence Main Business and Company’s Total Revenue
5.3.3 Boehringer Ingelheim BioXcellence Products, Services and Solutions
5.3.4 Boehringer Ingelheim BioXcellence Revenue (US$ Million) (2015-2020)
5.3.5 Thermo Fisher Scientific Recent Development and Reaction to Covid-19
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business and Company’s Total Revenue
5.4.3 Thermo Fisher Scientific Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Revenue (US$ Million) (2015-2020)
5.4.5 Thermo Fisher Scientific Recent Development and Reaction to Covid-19
5.5 Samsung BioLogics
5.5.1 Samsung BioLogics Profile
5.5.2 Samsung BioLogics Main Business and Company’s Total Revenue
5.5.3 Samsung BioLogics Products, Services and Solutions
5.5.4 Samsung BioLogics Revenue (US$ Million) (2015-2020)
5.5.5 Samsung BioLogics Recent Development and Reaction to Covid-19
5.6 AGC Biologics
5.6.1 AGC Biologics Profile
5.6.2 AGC Biologics Main Business and Company’s Total Revenue
5.6.3 AGC Biologics Products, Services and Solutions
5.6.4 AGC Biologics Revenue (US$ Million) (2015-2020)
5.6.5 AGC Biologics Recent Development and Reaction to Covid-19
5.7 Catalent
5.7.1 Catalent Profile
5.7.2 Catalent Main Business and Company’s Total Revenue
5.7.3 Catalent Products, Services and Solutions
5.7.4 Catalent Revenue (US$ Million) (2015-2020)
5.7.5 Catalent Recent Development and Reaction to Covid-19
5.8 Wuxi Biologics
5.8.1 Wuxi Biologics Profile
5.8.2 Wuxi Biologics Main Business and Company’s Total Revenue
5.8.3 Wuxi Biologics Products, Services and Solutions
5.8.4 Wuxi Biologics Revenue (US$ Million) (2015-2020)
5.8.5 Wuxi Biologics Recent Development and Reaction to Covid-19

6 North America Biologics Contract Development and Manufacturing Organization(CDMO) by Players and by Application
6.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Market Share by Players (2015-2020)
6.2 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)

7 Europe Biologics Contract Development and Manufacturing Organization(CDMO) by Players and by Application
7.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Market Share by Players (2015-2020)
7.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)

8 China Biologics Contract Development and Manufacturing Organization(CDMO) by Players and by Application
8.1 China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Market Share by Players (2015-2020)
8.2 China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)

9 Rest of Asia Pacific Biologics Contract Development and Manufacturing Organization(CDMO) by Players and by Application
9.1 Rest of Asia Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)

10 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) by Players and by Application
10.1 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Market Share by Players (2015-2020)
10.2 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)

11 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) by Players and by Application
11.1 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)

12 Biologics Contract Development and Manufacturing Organization(CDMO) Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis

13 Research Finding /Conclusion

14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
  • FORMAT: PDF
  • PUBLISHED DATE: Nov, 2020
  • NO OF PAGES: 125